CHRNA7 and Airway obstruction: Because HIV gp120 uses the α7-nAChR/GABAARα2 pathway to trigger airway mucus formation and mucous cell hyperplasia, α7nAChR and GABAARα2 antagonists may have beneficial effects in reducing mucus formation and development of obstructive lung diseases and lung infections in HIV-infected subjects.